UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center
UCSF navigation bar
  UCSF arrow indicating deeper hierarchy A-Z Index of Webs arrow indicating deeper hierarchy U arrow indicating deeper hierarchyDepartment of Urology arrow indicating deeper hierarchyFaculty arrow indicating deeper hierarchy Rajvir Dahiya, PhD  
Department of Urology   search
Department of Urology

Rajvir Dahiya, PhD

Biographical Sketch

MS, 1978, Kurukshetra University, India, Physiology/Biochemistry

PhD, 1983, Post Graduate Institute of Medical Education & Research, Chandigarh, India, Biochemistry/Experimental Medicine

 

1983-1987

Research Associate, Biochemistry & Medicine, University of Chicago, IL

1987-1993

Senior Scientist, Veterans Affairs Medical Center, University of California, San Francisco, CA

1991-Present

Director of Urology Research Center, Department of Urology, Veterans Affairs Medical Center, University of California, San Francisco, CA

1993-1997

Associate Professor, Department of Urology, University of California, San Francisco, CA

1997-Present

Professor, Department of Urology, University of California, San Francisco, CA

 

Rajvir Dahiya received his PhD in the field of Experimental Medicine and Biochemistry from the Post Graduate Institute of Medical Education and Research in Chandigarh, India. He completed four years of post-doctoral fellowship training in oncology and molecular biology at the University of Chicago Pritzker School of Medicine in Chicago, IL. Dahiya joined the University of California, San Francisco (UCSF) School of Medicine in 1987 as a scientist located at the San Francisco Veterans Affairs Medical Center (VAMC). He became director of the UCSF/VAMC Urology Research Center in 1991.

Dahiya is a scientific advisor and reviewer, and chairman for the United States Army Department of Defense’s (DOD) medical research programs in prostate, breast and ovarian cancer. He is a member and chairman of scientific review committees for the National Institutes of Health (NIH) including the National Cancer Institute (NCI), the National Institutes of Digestive Diseases and Kidney (NIDDK) and the National Institute of Aging (NIA). As a committee member and chairman, he reviews scientific progress and future plans for comprehensive cancer center programs, the George O’Brien Research Center, the NCI funded Specialized Program for Research Excellence (SPORE); postdoctoral fellow training programs; program projects related to oncology and research projects related to urologic oncology. Dahiya is a medical research advisor and scientific reviewer for numerous international programs and universities including institutions located in Europe, Israel, Japan Korea and Brazil.

Dahiya is the President of the International Cancer Research Association, the Society of American Asian Scientists in Cancer Research, and the American Association of Indian Scientists in Cancer Research. The members of these associations are medical scientists from North America, South America, Europe and Asia. The associations convene to discuss the latest medical science discoveries, exchange novel ideas and foster collaboration in the field of cancer prevention, early diagnosis, prognosis and cancer treatment through novel strategies.

Dahiya has published over 200 original research manuscripts in national and international journals. He has written chapters in books and holds multiple oncology patents. Dahiya has a long-standing interest in molecular genetic targets as novel biomarkers for the early diagnosis and prognosis of cancer.

Dahiya is a program director for many research projects. These include: the Center for Excellence in Prostate Cancer funded by the Department of Veterans Affairs, Washington DC; the Urological Research Training program funded by NIH/NIDDK; VA Merit Review funded by the Department of Veterans Affairs, Washington DC; DNA methylation in aging and prostate cancer program funded by NIA; Estrogen metabolizing genes and race-related prostate cancer by the NCI; and genetic polymorphisms and prostate cancer program funded by the United States Army (DOD) Medical Research.